You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti-SARS-CoV-2 Vaccine

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Coadministration of Influenza Vaccination With Booster Dose of

Completed
  • Co-administration of COVID-19 and Influenza Vaccines
  • COMIRNATY
  • Roma, RM, Italy
    Fondazione Policlinico Gemelli
Mar 10, 2023

Covid-19 Vaccine Response in Elderly Subjects

Active, not recruiting
  • Covid19 Vaccine
  • Specific antibody and cellular immune response after anti-SARS-CoV-2 vaccine administration
  • Lille, France
    CHU lille
Apr 28, 2022

COVID-19 Vaccine Efficacy in Patients With Malignant Pathologies

Recruiting
  • Solid Tumor
  • +4 more
  • Data collection
  • Paris, France
  • +1 more
Nov 26, 2021

IgG Antibodies After SARS-CoV-2 mRNA Vaccine in Kidney

Active, not recruiting
  • Kidney Transplantation
  • anti-spike SARS-CoV-2 IgG
  • Prague, Czechia
    Institute for Clinical and Experimental Medicine
Dec 16, 2021

COVID-19 Trial in Brazil (BCG (Bacillus Calmette-Guérin) vaccine, Placebo)

Recruiting
  • COVID-19
  • BCG (Bacillus Calmette-Guérin) vaccine
  • Placebo
  • Manaus, Amazonas, Brazil
  • +3 more
Aug 17, 2022

Sarcoidosis, SARS-CoV2 Infection, Vaccine Response Impaired Trial in Chicago (Assay of (1) the level of anti-spike IgG antibody,

Recruiting
  • Sarcoidosis
  • +2 more
  • Assay of (1) the level of anti-spike IgG antibody, and (2) interferon-gamma release in response to SARS-CoV-2 antigen stimulation
  • Chicago, Illinois
    Northwestern Medicine
Dec 6, 2021

Kidney Transplant Recipient Trial in Phoenix, Jacksonville, Rochester (Janssen Ad26.CoV2.S Vaccine, Reduction in

Recruiting
  • Kidney Transplant Recipient
  • Janssen Ad26.CoV2.S Vaccine
  • +2 more
  • Phoenix, Arizona
  • +2 more
Jul 14, 2022

COVID-19 Trial (AV-COVID-19)

Not yet recruiting
  • COVID-19
  • AV-COVID-19
  • (no location specified)
Dec 14, 2021

COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in

Not yet recruiting
  • Follicular Lymphoma
  • Cellular immunity vs SARS-CoV-2
  • +6 more
  • Alessandria, IT, Italy
  • +13 more
Oct 10, 2023

After COVID-19 Vaccination Among Patients Under Hemodialysis

Completed
  • Covid19
  • +3 more
  • Elecsys Anti-SARS-CoV-2 S (Roche Diagnostics GmbH, Mannheim, Germany), 2) ACCESS SARS-CoV-2 IgG II (Beckman Coulter, Inc. USA)
  • Seoul, Korea, Republic of
    Hanyang University Seoul Hospital
Mar 16, 2022

COVID-19 Trial in Semarang (AV-COVID-19, GM-CSF)

Completed
  • COVID-19
  • AV-COVID-19
  • GM-CSF
  • Semarang, Jawa Tengah, Indonesia
    Rumah Sakit Umum Pusat Dr. Kariadi
Dec 14, 2021

SARS-CoV-2 Trial in Chengdu (SARS-CoV-2 mRNA vaccine (RBMRNA), CoronaVac®)

Active, not recruiting
  • SARS-CoV-2
  • SARS-CoV-2 mRNA vaccine (RBMRNA)
  • CoronaVac®
  • Chengdu, Sichuan, China
    Chengdu Xinhua Hospital affiliated to North Sichuan Medical Coll
Jun 12, 2023

COVID-19 Vaccine and Ovarian Reserve

Active, not recruiting
  • Fertility Issues
  • Vaccine Adverse Reaction
  • SARS-CoV-2 virus vaccines
  • +2 more
  • Ramat-Gan, Israel
    Sheba Medical Center
Apr 6, 2022

Vaccine Reaction Trial in Zurich (Venous bleeding)

Active, not recruiting
  • Vaccine Reaction
  • Venous bleeding
  • Zurich, Switzerland
    Univeristy Hospital Zurich
Aug 29, 2021

COVID-19 Trial in Wong Chuk Hang (SARS-CoV-2 DNA Vaccine (ICCOV))

Recruiting
  • COVID-19
  • SARS-CoV-2 DNA Vaccine (ICCOV)
  • Wong Chuk Hang, Hong Kong
    Gleneagles Hospital Hong Kong
Jun 16, 2023

SARS-CoV-2 Trial in Chengdu (RBMRNA-176, Placebo)

Active, not recruiting
  • SARS-CoV-2
  • RBMRNA-176
  • Placebo
  • Chengdu, Sichuan, China
    Chengdu Xinhua Hospital affiliated to North Sichuan Medical Coll
Jun 12, 2023

SARS-CoV-2 Infection, Varicella, Measles Trial in Shanghai (Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine,

Not yet recruiting
  • SARS-CoV-2 Infection
  • +4 more
  • Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Municipal Center for Disease Control and Prevention
Jul 17, 2023

SARS-CoV-2 Trial (SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine low dose, SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine high

Not yet recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine low dose
  • +2 more
  • (no location specified)
Dec 1, 2022

SARS-CoV-2 Trial in Nanjing (SARS-CoV-2 Bivalent mRNA Vaccine, Recombinant SARS-CoV-2 vaccine, Saline)

Not yet recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Bivalent mRNA Vaccine
  • +2 more
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Disease Control and Prevention
Jul 7, 2023

SARS-CoV-2 Trial in Bengbu (SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine Low dose, SARS-CoV-2 Variant (Omicron BA.5) mRNA

Active, not recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine Low dose
  • +2 more
  • Bengbu, Anhui, China
    First Affiliated Hospital Bengbu Medical College
Jan 3, 2023

COVID-19 Infection, COVID-19 Vaccine Adverse Reaction Trial in Seoul (LEM-mR203, Placebo)

Not yet recruiting
  • COVID-19 Infection
  • COVID-19 Vaccine Adverse Reaction
  • LEM-mR203
  • Placebo
  • Seoul, Korea, Republic of
    Seoul National University Hospital Clinical Trials Center
Sep 12, 2023

SARS-CoV-2 Trial in Nanjing (SARS-CoV-2 Bivalent mRNA Vaccine, Saline)

Not yet recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Bivalent mRNA Vaccine
  • Saline
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Disease Control and Prevention
Jul 7, 2023

SARS-CoV-2 Infection Trial in Mexico City (Recombinant NDV Vectored Vaccine for SARS-CoV-2)

Completed
  • SARS-CoV-2 Infection
  • Recombinant NDV Vectored Vaccine for SARS-CoV-2
  • Mexico City, Ciudad De Mexico, Mexico
    Hospital Medica Sur
Dec 8, 2022

COVID-19 Trial in Guangzhou (the recombinant SARS-CoV-2 S-Trimer vaccine/inactivated SARS-CoV-2 vaccine)

Recruiting
  • COVID-19
  • the recombinant SARS-CoV-2 S-Trimer vaccine/inactivated SARS-CoV-2 vaccine
  • Guangzhou, Guangzhou, China
    The Fifth Affiliated Hospital of Guangzhou Medical University
Jan 28, 2023

Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE), Pemphigus Vulgaris Trial in United States (Moderna mRNA-1273,

Recruiting
  • Rheumatoid Arthritis
  • +8 more
  • Moderna mRNA-1273
  • +5 more
  • Los Angeles, California
  • +24 more
Aug 17, 2022